Assignment: Design of Toradol CPOE and CDSS

Assignment: Design of Toradol CPOE and CDSS

Assignment: Design of Toradol CPOE and CDSS

CPOE and CDSS Instructions

For this assignment, select one clinical practice issue that involves a specific medication. Using a Computerized Provider Order Entry (CPOE) system, design a Clinical Decision Support System (CDSS) that would be embedded in the EHR at your site of practice. Your CDSS must connect with CPOE to include a medication. You must link these two applications within the design.

General Guidelines:

Use the following information to ensure successful completion of the assignment:

• This assignment uses a rubric. Please review the rubric prior to beginning the assignment to become familiar with the expectations for successful completion.
• Doctoral learners are required to use APA style for their writing assignments. The APA Style Guide is located in the Student Success Center.
• Use primary sources published within the last 5 years. Provide citations and references for all sources used.
• You are required to submit this assignment to LopesWrite. Refer to the directions in the Student Success Center.

Directions:

Write a 1,000-1,250 word paper that provides the following:

• Specific details of the clinical issue involving a specific medication
• The rationale behind your design development.
• A description of how this CDSS will be implemented and adopted by fellow clinicians.
• An assessment of challenges and proposed solutions which might apply to this scenario (e.g., information loss, communication breakdown).

KINDLY ORDER NOW FOR A CUSTOM-WRITTEN, PLAGIARISM-FREE PAPER

Assignment: Design of Toradol CPOE and CDSS

Rubric:

Course Code	Class Code	Assignment Title	Total Points
DNP-805	DNP-805-O500	Using CPOE and CDSS	100.0
Criteria	Percentage	Unsatisfactory (0.00%)	Less than Satisfactory (74.00%)	Satisfactory (79.00%)	Good (87.00%)	Excellent (100.00%)	Comments	Points Earned
Content	70.0%
Computerized Provider Order Entry (CPOE) Used to Design a Clinical Decision Support System (CDSS)	15.0%	CPOE was not used to design a CDSS.	CPOE was used to design a CDSS but use is marginal or incomplete.	CPOE was used to design a CDSS but used at a perfunctory level.	CPOE was used to design a CDSS in full. Discussion is convincing. Information presented is from scholarly though dated sources.	CPOE was used to design a CDSS in full. Discussion is insightful and forward-thinking. Information presented is from current scholarly sources.
Proposed CDSS Embedded in the EHR	15.0%	Proposed CDSS is not embedded in the EHR.	Proposed CDSS is embedded in the EHR but use is marginal or incomplete.	Proposed CDSS is embedded in the EHR but at a perfunctory level.	Proposed CDSS is embedded in the EHR in full. Discussion is convincing and defines specific elements. Information presented is from scholarly though dated sources.	Proposed CDSS is embedded in the EHR in full. Discussion is convincing and defines specific elements. Discussion is insightful and forward-thinking. Information presented is from current scholarly sources.
Proposed CDSS Design Links a  Specific Medication Through the CPOE	5.0%	Proposed CDSS design does not link a specific medication through the CPOE.	Proposed CDSS design links a specific medication through the CPOE but effort is marginal or incomplete.	Proposed CDSS design links a specific medication through the CPOE but at a perfunctory level.	Proposed CDSS design links a specific medication through the CPOE in full. Discussion is convincing and defines specific elements. Information presented is from scholarly though dated sources.	Proposed CDSS design links a specific medication through the CPOE in full. Discussion is convincing and defines specific elements. Discussion is insightful and forward-thinking. Information presented is from current scholarly sources.
Discussion of Specific Details of Clinical Issue Involving the Selected Medication	5.0%	Discussion of specific details of the clinical issue involving the selected medication is not present.	Discussion of specific details of the clinical issue involving the selected medication is present but incomplete.	Discussion of specific details of the clinical issue involving the selected medication is present but rendered at a perfunctory level.	Discussion of specific details of the clinical issue involving the selected medication is convincing and thorough. Information presented is from scholarly though dated sources.	Discussion of specific details of the clinical issue involving the selected medication is convincing and thorough. Discussion is insightful and forward-thinking. Information presented is from current scholarly sources.
Discussion of the Rationale Behind the Design Development	5.0%	A discussion of the rationale behind the design development is not present. Assignment: Design of Toradol CPOE and CDSS	A discussion of the rationale behind the design development is present but incomplete.	A discussion of the rationale behind the design development is present but rendered at a perfunctory level.	A discussion of the rationale behind the design development is convincing and defines specific elements. Information presented is from scholarly though dated sources.	A discussion of the rationale behind the design development is convincing and defines specific elements. Discussion is insightful and forward-thinking. Information presented is from current scholarly sources.
Description of How Proposed CDSS Will Be Implemented and Adopted by Fellow Clinicians	10.0%	Does not describe how the proposed CDSS will be implemented and adopted by fellow clinicians.	A description of how the proposed CDSS will be implemented and adopted by fellow clinicians is present but incomplete.	A description of how the proposed CDSS will be implemented and adopted by fellow clinicians is present but rendered at a perfunctory level.	A description of how the proposed CDSS will be implemented and adopted by fellow clinicians is present in full. Discussion is convincing and defines specific elements. Information presented is from scholarly though dated sources.	A description of how the proposed CDSS will be implemented and adopted by fellow clinicians is present in full. Discussion is convincing and defines specific elements. Discussion is insightful and forward-thinking. Information presented is from current scholarly sources.
Explanation of How Patient Outcomes Will Be Measured	5.0%	Does not provide an explanation of how patient outcomes will be measured.	Provides an explanation of how patient outcomes will be measured but explanation is incomplete. Assignment: Design of Toradol CPOE and CDSS Assignment: Design of Toradol CPOE and CDSS	Provides an explanation how patient outcomes will be measured but explanation is rendered at a perfunctory level.	Provides an explanation how patient outcomes will be measured in full. Discussion is convincing and defines specific elements. Information presented is from scholarly though dated sources.	Provides an explanation how patient outcomes will be measured in full. Discussion is convincing and defines specific elements. Discussion is insightful and forward-thinking. Information presented is from current scholarly sources.
Assessment of Challenges and Proposed Solutions Which Might Apply to Scenario	10.0%	Does not provide an assessment of challenges and proposed solutions which might apply to this scenario.	Provides an assessment of challenges and proposed solutions which might apply to this scenario, but elements are missing or incomplete.	Provides an assessment of challenges and proposed solutions which might apply to this scenario, but assessment is rendered at a perfunctory level.	An assessment of challenges and proposed solutions which might apply to this scenario is clearly presented and thorough. Discussion is convincing and defines specific elements. Information presented is from scholarly though dated sources.	An assessment of challenges and proposed solutions which might apply to this scenario is clearly presented and thorough. Discussion is insightful, forward-thinking, and detailed. Information presented is from current scholarly sources.
Organization & Effectiveness	20.0%
Thesis Development and Purpose	7.0%	Paper lacks any discernible overall purpose or organizing claim.	Thesis is insufficiently developed or vague. Purpose is not clear.	Thesis is apparent and appropriate to purpose.	Thesis is clear and forecasts the development of the paper. Thesis is descriptive and reflective of the arguments and appropriate to the purpose.	Thesis is comprehensive and contains the essence of the paper. Thesis statement makes the purpose of the paper clear.
Argument Logic and Construction	8.0%	Statement of purpose is not justified by the conclusion. The conclusion does not support the claim made. Argument is incoherent and uses noncredible sources.	Sufficient justification of claims is lacking. Argument lacks consistent unity. There are obvious flaws in the logic. Some sources have questionable credibility.	Argument is orderly, but may have a few inconsistencies. The argument presents minimal justification of claims. Argument logically, but not thoroughly, supports the purpose. Sources used are credible. Introduction and conclusion bracket the thesis.	Argument shows logical progressions. Techniques of argumentation are evident. There is a smooth progression of claims from introduction to conclusion. Most sources are authoritative.	Clear and convincing argument that presents a persuasive claim in a distinctive and compelling manner. All sources are authoritative.
Mechanics of Writing (includes spelling, punctuation, grammar, language use)	5.0%	Surface errors are pervasive enough that they impede communication of meaning. Inappropriate word choice and/or sentence construction are used.	Frequent and repetitive mechanical errors distract the reader. Inconsistencies in language choice (register) or word choice are present. Sentence structure is correct but not varied.	Some mechanical errors or typos are present, but they are not overly distracting to the reader. Correct and varied sentence structure and audience-appropriate language are employed	Prose is largely free of mechanical errors, although a few may be present. A variety of sentence structures and effective figures of speech are used.	Writer is clearly in command of standard, written, academic English.
Format	10.0%
Paper Format (Use of appropriate style for the major and assignment)	5.0%	Template is not used appropriately or documentation format is rarely followed correctly.	Appropriate template is used, but some elements are missing or mistaken. A lack of control with formatting is apparent.	Appropriate template is used. Formatting is correct, although some minor errors may be present.	Appropriate template is fully used. There are virtually no errors in formatting style.	All format elements are correct.
Documentation of Sources (citations, footnotes, references, bibliography, etc., as appropriate to assignment and style)	5.0%	Sources are not documented.	Documentation of sources is inconsistent or incorrect, as appropriate to assignment and style, with numerous formatting errors.	Sources are documented, as appropriate to assignment and style, although some formatting errors may be present.	Sources are documented, as appropriate to assignment and style, and format is mostly correct.	Sources are completely and correctly documented, as appropriate to assignment and style, and format is free of error.
		Assignment: Design of Toradol CPOE and CDSS
Total Weightage	100%